MEGESTROL

Course overview

MEGESTROL IS A MEDICATION USED TO MANAGE AND TREAT SIGNIFICANT, INEXPLICABLE WEIGHT LOSS IN HIV/AIDS PATIENTS AND ANOREXIA OR CACHEXIA SYNDROME. IT IS IN THE PROGESTIN CLASS OF DRUGS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR MEGESTROL AS A VALUABLE AGENT IN MANAGING SIGNIFICANT, INEXPLICABLE WEIGHT LOSS IN HIV/AIDS PATIENTS AND ANOREXIA OR CACHEXIA SYNDROME. IN ADDITION, THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS, INCLUDING OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, AND MONITORING, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS WITH SIGNIFICANT, INEXPLICABLE WEIGHT LOSS IN HIV/AIDS PATIENTS AND ANOREXIA OR CACHEXIA SYNDROME, AND RELATED CONDITIONS.